Satcher Health Leadership Institute At Morehouse School Of Medicine, With Support From Google.org And Gilead Sciences, Launches Health Equity Tracker To Study Racial Health Inequities Related To Covid-19 Biotech Investing
Xencor and Bristol Myers Squibb Enter License Agreement for Use of Xtend XmAb® Technology in SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment of COVID-19 Biotech Investing
AbbVie Showcases the Depth of its Rheumatology Portfolio with New Data Presented at the EULAR 2021 Virtual Congress of Rheumatology Biotech Investing
AbbVie Receives European Commission Approval of VENCLYXTO® in Combination with a Hypomethylating Agent for Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy Biotech Investing
Bristol Myers Squibb to Host Virtual Investor Event to Discuss ASCO 2021 Highlights Biotech Investing
Enveric Biosciences Announces Definitive Agreement to Acquire MagicMed Industries, a Pharmaceutical Drug Discovery and Development Platform Focused on New-Generation Psychedelic Molecular Compounds and Derivatives Pharmaceutical Investing
AbbVie Presents New Late-Breaking Data Analyses Showing Risankizumab Achieves Clinical Remission and Endoscopic Response at Week 12 in Patients with Moderate to Severe Crohn's Disease Biotech Investing
Bristol Myers Squibb Presents New Data at Digestive Disease Week® on Zeposia Highlighting Clinical Benefits and Safety Profile in Patients with Ulcerative Colitis Biotech Investing
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Opdivo plus Yervoy for Treatment of Mismatch Repair Deficient or Microsatellite Instability-High Metastatic Colorectal Cancer After Prior Chemotherapy Biotech Investing
